Tonix Pharmaceuticals Holding (TNXP) Work In Process (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Work In Process for 3 years, with the latest figure at $1.4 million in Q4 2025.

• On a quarterly basis, Work In Process rose 543.19% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 543.19% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 543.19% from the prior year.
• Work In Process was $1.4 million for Q4 2025 at Tonix Pharmaceuticals Holding, down from $1.5 million in the prior quarter.
• The five-year high for Work In Process was $2.5 million in Q4 2023, with the low at $213000.0 in Q4 2024.
• Average Work In Process over 3 years is $1.4 million, with a median of $1.4 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Work In Process plunged 91.61% in 2024, then soared 543.19% in 2025.
• Over 3 years, Work In Process stood at $2.5 million in 2023, then slumped by 91.61% to $213000.0 in 2024, then jumped by 543.19% to $1.4 million in 2025.
• The last three Work In Process figures came in at $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.